Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.
Fang LiuYu PengHui QianMeng Chao XiaoChen Hong DingXin ZhangWei Fen XiePublished in: Journal of digestive diseases (2024)
Our data revealed that inhibiting K458 acetylation of HNF4α might provide a more promising candidate for differential therapy of HCC.